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The U. S. Navy implemented the Self-Paced Airsickness Desensitization (SPAD)
program in 1989 for aviation students whose incidence of airsickness was not easily
resolved. Some participants may have also experienced symptoms that are not typically
recognized as motion sickness, including prolonged drowsiness and/or mood changes.
These effects are part of a poorly understood response to motion termed "Sopite
Syndrome." This thesis explores the effects of Sopite Syndrome on student aviators
diagnosed with motion sickness. Sixty SPAD program participants completed a survey
comprised of scales, which estimate motion sickness, drowsiness, fatigue, and sleep
disturbances during SPAD treatment days. Results indicate: (1) symptoms consistent of
Sopite Syndrome were reported by 45% of the participants and (2) the presence of Sopite
Syndrome in a SPAD participant was not an accurate predictor for successful treatment
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Airsickness is one of the problems encountered by student aviators while
attempting to adapt to the foreign environment of aviation. It is considered among the
most provocative forms of motion sickness (Strongin & Charlton, 1991). The incidence
of airsickness in navigators has been estimated at 22%, and the associated cost includes
delay of flight training, incomplete flight events, and rescheduling of flights (Royal,
Jessen, & Wilkens, 1984). Additionally, such episodes with airsickness may be severe
enough to interfere with control of the aircraft (Dehart, 1985). Therefore, motion
sickness during flight training continues to be an expensive and difficult issue, especially
in the military. The effects of airsickness on student aviators include nausea to the point
of incapacitation, vomiting, degraded flight performance or premature termination of
flight (NOMI, 1997).
The U. S. Navy implemented a treatment program in 1989 for aviation students
whose incidence of airsickness was not easily resolved. The Self-Paced Airsickness
Desensitization (SPAD) program requires a participant to adapt during a four- to six-
week duration to repeated head movements in four directions during gradually increasing
rates of on-center rotation. Some SPAD participants may have also experienced
symptoms that are not typically recognized as motion sickness, including prolonged
drowsiness and/or mood changes (Lawson & Mead, 1997). These effects are part of a
poorly understood response to motion termed "Sopite Syndrome." Graybiel and Knepton
(1976) defined Sopite Syndrome as extreme drowsiness, fatigue, and mood changes.
Remarkably, the impact of Sopite Syndrome on military aviation is virtually unknown
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(Lawson & Mead, 1997). Research has recently been initiated to explore Sopite
Syndrome's effect on student aviators who participated in the SPAD program.
The purpose of this study was to determine the effects of Sopite Syndrome on
student aviators diagnosed with motion sickness who participated in the SPAD program.
Specifically, it assessed the presence of Sopite Syndrome symptoms in SPAD
participants and their relationship with successful completion of treatment and return to
flight status. Sixty SPAD participants completed a multiple scale survey intended to
estimate motion experience, motion sickness, mood changes, drowsiness, fatigue, and
sleep disturbances during days on which they were subjected to controlled rotation. The
scales were designed to detect the various symptoms associated with Sopite Syndrome.
Exploratory analyses combined with hypothesis testing of the survey data were
performed to evaluate the relationships between the different survey scales and to
determine the percentage of SPAD participants who experienced increased severity in
symptoms during training. The analyses reveal that all of the scales (i.e. Sleep, Motion
Sickness During SPAD Training, Mood, Drowsiness During SPAD Training, and
Fatigue), with the exception of motion sickness, appear to be significantly related to one
another. The actual percentage of respondents who reported increases between the two
conditions was 53% for the sleep scale, 98% for the motion sickness scale, 45% to 85%
for each of the 16 moods that were prevalent in student aviators who were referred to the
SPAD program, 87% for the drowsiness scale, 90% for the sleepiness rating scale, and
70% for the fatigue scale.
A symptomatic profile for Sopite Syndrome candidates was developed based
upon the literature. From the original sample population of 60 former SPAD participants,
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27 (45%) of them exhibited symptoms characteristic of Sopite Syndrome. Of these 27
individuals, 19 (70%) of them were returned to flight status. Furthermore, of the 33
remaining SPAD participants not classified as exhibiting symptoms characteristic of
Sopite Syndrome, 28 (85%) were returned to flight status. The research concluded that
the presence of Sopite Syndrome in a SPAD participant was not an accurate predictor for





The Naval Aerospace Medical Research Laboratory (NAMRL) was established in
1939 at the Naval Air Station, Pensacola. Currently, NAMRL has three departments:
Biomedical Systems and Standards, Spatial Orientation Systems, and Aviation and
Operational Medicine. The primary responsibility of the research laboratory is to
conduct research and development in aviation medicine and allied sciences to enhance
the health, safety, and readiness of Navy and Marine Corps personnel in the performance
of their missions. (NAMRL, 1997)
In 1989, NAMRL established as part of the Aviation and Occupational Medicine
department an airsickness rehabilitation program: Self-Paced Airsickness Desensitization
(SPAD) (Naval Operational Medical Institute- NOMI, 1997). The SPAD program was
established for aviators who were unable to adapt quickly to the nauseogenic (that is,
inducing nausea) aviation training environment. The program's protocol includes
psychological desensitization with "autogenic," self-produced, biofeedback and physical
desensitization in a rotating chair with continuous biofeedback monitoring. Successful
completion of the program stated is the adaptation to airsickness symptoms during a spin
rate of 20 rpm for 40 minutes without problems (NOMI, 1997). This is usually
accomplished by spinning at 16 rpm for 10 minutes, 18 rpm for 10 minutes and then 20
rpm for 40 minutes. For those aviators who attend the SPAD program, there is a 68%
success rate for returning to flight status (Gallagher, Hopkins, Moore, & Valbracht,
1997).
It is possible that SPAD participants also experience symptoms that are not often
recognized as motion sickness. This includes prolonged drowsiness and/or mood
changes. Lawson and Mead (1997) state that these effects are part of a poorly understood
manifestation of motion sickness known as "Sopite Syndrome." Sopite Syndrome
derives its name from the Latin "sopire" which means to put to sleep (Woolf, 1981).
Graybiel and Knepton (1976) formally named the syndrome upon accumulating sufficient
scientific and clinical evidence through research in NAMRL's slow rotation room. The
primary Sopite Syndrome symptoms are extreme drowsiness, fatigue, mood changes,
disinclination to work, apathy, irritability, mental depression, sleep disturbances, and
difficulty concentrating (Graybiel & Knepton, 1976; Graybiel, Kennedy, Knoblock,
Guedry, Mertz, McCleod, Colehour, Miller, & Fregly, 1965). Sopite Syndrome may
occur during or after flight, and can exist in isolation from more apparent symptoms of
"regular" motion sickness such as nausea and vomiting (Lawson & Mead, 1997).
Furthermore, Lawson and Mead (1997) state it can last long after nausea has disappeared
and can debilitate some individuals. The syndrome can be extremely hazardous in
military operations where sleep deprivation and other performance challenges may exist.
Sopite Syndrome may have as much impact on military aviation flight
performance as the more commonly recognized symptoms of motion sickness (Lawson &
Mead, 1997). Lawson and Mead (1997) contend that as the Navy prepares for the future,
research into this motion-related syndrome will be of key importance to aerospace
training and operations. The focus of this thesis is to determine the incidence and effects
of Sopite Syndrome on individuals diagnosed with "regular" motion sickness who
participated in the SPAD rehabilitation program. Additionally, it will explore the
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association of Sopite Syndrome with the successful completion of SPAD treatment by
student aviators and ultimate return to flight status.
B. PURPOSE
The purpose of this thesis is to investigate the responses to a survey and determine
if personnel diagnosed with motion sickness exhibit symptoms characteristic of Sopite
Syndrome.
C. PROBLEM STATEMENT
Airsickness continues to be a significant issue for student aviators. NOMI (1997)
states the cost of airsickness includes delay in flight training, rescheduling of flights,
incomplete flight events, and the potential loss of situational awareness and in-flight
performance degradation. The U.S. Navy's SPAD program desensitizes aviation students
who have demonstrated difficulty adapting to the motional environment experienced in
aircraft. However, this desensitization is limited to motion sickness symptoms (i.e.,
nausea, vomiting, etc.). Therefore, Sopite Syndrome symptoms potentially remain
untreated in student aviators who participate in the SPAD program. The existence and
impact of Sopite Syndrome on this population of student aviators is unknown.
The possible existence of Sopite Syndrome in student aviators who participated in
the SPAD program makes it worthy of increased attention. An assessment of the
incidence and magnitude of Sopite symptoms including an estimate of predisposing
factors can be made in this specific training environment. Furthermore, due to the
potential hazard of Sopite Syndrome in Naval aviation, an analysis of the survey data
must be undertaken. This thesis investigated the following research questions:
1.
What are the central tendencies and dispersions of the respective survey scale
(i.e. Sleep, Motion Sickness During SPAD Training, Mood, Drowsiness during SPAD
Training, and Fatigue) responses? Additionally, are the paired differences between the
"During SPAD" and "In General" response values statistically significant for each of the
survey scales?
2. Which of the original 49 moods in the Mood scale are most prevalent in
student aviators who were referred to the SPAD rehabilitation program?
3. What are the relationships that exist between the respective survey scales and
are these relationships statistically significant?
4. What percentage of student aviators who participated in the SPAD
rehabilitation program exhibited symptoms characteristic of Sopite Syndrome?
Furthermore, what percentage of Sopite candidates were subsequently either returned or
not returned to flight status upon completion of the SPAD rehabilitation program?
5. Are the paired difference scores between the Sopite and Non-Sopite candidates
statistically significant for each of the respective survey scales?
6. Which of the Sleep and Fatigue scale questions are most indicative of Sopite
Syndrome candidates?
D. SCOPE AND LIMITATIONS
The surveys analyzed in this study are limited to the 60 completed surveys that
were returned by previous participants in the SPAD program. All of the subjects had
been previously diagnosed with motion sickness, so a comparison of the results with




In researching literature for this thesis, insight and direction has been provided by
scientists located at NOMI and NAMRL at NAS Pensacola. Various resources included
civilian and government on-line medical services, Naval library assets (i.e., journals,
records and etc.), and motion sickness periodicals and publications. The scope of the
subject matter included the annals of motion sickness symptomatology, preventive
antidotes and medications, and debilitating effects and hazards imposed on personnel in
various fields of transportation. The extent of the research focused on a response to
motion known as Sopite Syndrome. Primary interest was focused on the effects of Sopite
Syndrome on humans and its distinction from that of "regular" motion sickness.
B. MOTION SICKNESS
Motion sickness is a chronic disease endured on highways, at sea, in the air, and
in space. The most readily perceived and easily recognized characteristics of motion
sickness are nausea, vomiting, drowsiness, pallor, cold sweating and/or loss of appetite
(Jozsvai & Pigeau, 1996). Specific symptoms that occur during unaccustomed motion
will depend upon on exposure conditions and the individual (DiZio & Lackner, 1992). A
wide variety of motions qualify as offensive; thus there are many names for motion
sickness, including carsickness, seasickness, train sickness, flight simulator sickness,
motion-picture sickness, and airsickness.
Airsickness is considered among the most provocative forms of motion sickness
(Strongin & Charlton, 1991). Flight in turbulent air with frequent sudden and
unanticipated changes in direction with little reference to spatial orientation is good
reason. Technological improvements in modern combat aircraft have dramatically
increased the probability that military aircrew will be exposed to these conditions for
extended periods. The novice aviator is inclined to have a higher frequency of
airsickness than the experienced aviator (Dobie, 1974). Therefore, motion sickness
during flight training continues to be an expensive and difficult issue, especially in the
military. The effects of airsickness on student aviators include nausea to the point of
incapacitation, vomiting, degraded flight performance or premature termination of flight
(NOMI, 1997).
Military experience with airsickness in World War II provided some interesting
statistics:
... it was learned that 10 to 11 percent of all flying students became air sick
during their first 10 flights, and that 1 to 2 percent of them were eliminated from
flying training for that reason. Other aircrew members in training had even
greater difficulty and the air sickness rate among them ran as high as 50 percent in
some cases. It was found that only fully trained combat crews, other than pilots,
sometimes became airsick which affected their combat efficiency (Dehart, 1985,
p. 372).
In more recent studies the incidence of airsickness in United States military flight training
reveal that approximately 1 1% to 38% of student aviators become airsick, dependent
upon aircraft type and the stage of training (Jones, Levy, Gardner, & Patterson, 1985;
Rubin, 1942). The incidence of airsickness in navigators has been estimated at 22%, and
the associated cost includes delay of flight training, incomplete flight events, and
rescheduling of flights (Royal, Jessen, & Wilkens, 1984). Additionally, such episodes
with airsickness may be severe enough to interfere with control of the aircraft (Dehart,
1985).
C. AIRSICKNESS REHABILITATION PROGRAMS
Bagshaw and Stott (1985) state that an essential trait of motion environments that
give rise to motion sickness is that they produce patterns of sensory input that are in
conflict with those based on past motion experience. Spontaneous adaptation to the
provocative motion in the flight environment commonly resolves the problem of
airsickness for student aviators (Banks, Salisbury, & Ceresia, 1992). However, for a
relatively small proportion of subjects, due to high susceptibility or a slow adaptive
response, motion sickness continues (Bagshaw & Stott, 1985). Such conditions impair
ability and erode confidence in those afflicted. The result is poor performance in training
and the increased likelihood of being removed from flight status. Bagshaw and Stott
(1985) state the designation of a student with continuing motion sickness problems can
only occur after a reasonable period has been allowed for spontaneous adaptation.
Furthermore, motion sickness susceptibility is not an indicator of a student aviator's
ability at the airborne task; motion-sick aviators once treated have gone on to be
outstanding pilots and navigators.
In some individuals, incidence of airsickness may be reduced by the use of
prophylactic drugs during the early stages of training. The Royal Air Force (RAF)
commonly uses 0.3 - 0.6 mg of hyoscine hydrobromide (Scopolamine USP), although
cinnarizine 15-30 mg has been found useful for flights of long duration (Bagshaw &
Stott, 1985). For student aviators in the RAF use of such drugs is prohibited for solo
flying. In the Canadian Forces (CF), airsickness is a significant obstacle in the training of
some student aviators (Banks et al., 1992). In conventional therapy, when organic
pathology is ruled out, and no contraindications exist, anti-emetic medication is
prescribed to subdue symptoms for a maximum of three dual-only flights (Banks et al.,
1992). An effective procedure with acceptable side-effects is the combining 25 mg of
phenrgan with 30 mg of ephedrine 60 to 90 minutes prior to flight. In the case of both the
Royal and Canadian Air Forces, if student aviators become airsick to the point of
vomiting while on medication, or during subsequent flights, the student may be grounded
and considered for rehabilitation (Bagshaw & Stott, 1985; Banks et al., 1992).
An overview of the RAF and CF Airsickness Rehabilitation Programs showed
marked similarities in subject identification and selection procedures. The rehabilitation
phase did vary in structure and content for the two countries. Banks, Salisbury, and




Phase One, consisting of biofeedback relaxation therapy;
2. Phase Two, consisting of ground-based desensitization therapy; and
3. Phase Three, consisting of in-flight desensitization therapy.
The RAF differed in design in that biofeedback relaxation therapy was not incorporated
and in the use of a high performance aircraft, the Hunter T7, for the in-flight phase of
desensitization (Bagshaw & Stott, 1992). Bagshaw and Stott (1992) state that in earlier
years of desensitization treatment it was considered important that no attempt should be
made to carry out maneuvers beyond the range of the training syllabus. This idea has
been set aside with the use of the Hunter T7 aircraft for rehabilitation flying. The student
aviator now progresses as far as capable, both in terms of provocative aircraft maneuver
that can be tolerated and building confidence to meet the demands of flying a high
performance aircraft. Upon successfully adapting to this aircraft the student aviator does
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not need to restrict his or her aspirations, nor the expectations of the assigned instructor,
nor his or her career to flying in a less provocative environment such as in helicopters and
transport aircraft.
D. SELF-PACED AIRSICKNESS DESENSITIZATION PROGRAM
If a student aviator in the United States Navy is unable to adapt to the aviation
cockpit after two or three flights due to airsickness and also has not shown a significant
reduction in symptoms by the end of these flights, he or she is unlikely to resolve the
issue spontaneously. Early treatment is indicated and a referral to the squadron's flight
surgeon is in order. At this point an aeromedical evaluation is performed on the student
to rule out medical causes of vomiting. Additionally, the flight surgeon will address the
student's motivation, performance, and interaction within the squadron and talk over the
patient's situation with the flight instructors involved in his or her training. If a specialist
consultation is not required, the flight surgeon will diagnose the airsickness as due to
poor adaptation. Prior to returning to the squadron and getting back into the cockpit,
each airsick-prone student is given information on airsickness that discusses associated
signs and symptoms. Additionally, information on airsickness countermeasures to
decrease susceptibility and techniques to help adjust to the flight environment are
provided. (NOMI, 1997)
Upon the flight surgeon's approval, airsick-prone students are then given an
opportunity to try antiemetic medications for the next three flights to see if they are then
able to adapt to motion in the cockpit (NOMI, 1997). The medication prescribed is
phenergan 25 mg with ephedrine 25 mg taken 60 minutes prior to flight. Scopolmaine,
meclizine, and dramamine are not recommended at present. For those airsick-prone
students who do not make progress in adapting to the aviation environment in the next
three subsequent flights, referral to NOMI for further evaluation is in order. Allowed
responses in the cockpit by a student following medication treatment is complete self-
control of, or minimal, symptoms, not to include vomiting or cognitive variations that
would result in reduced flight performance or hasty termination of a mission (NOMI,
1997). Automatic referral is imposed on students who are incapacitated or affected by
reoccurring vomiting episodes after one or two flights while on medication.
Internal Medicine and Psychiatry are identified in NOMI (1997) as the primary
departments responsible for the administration and conduct of the motion sickness
desensitization program. However, when required NOMI will refer students to ENT,
Opthalmology and Neurology. NOMI will schedule initial neurologic and vestibular
evaluations, followed by a psychological interview including the Minnesota Multiphasic
Personality Inventory and family history. Once the evaluation is completed and further
appraisal is not necessary, the student is deemed appropriate to begin treatment in the
Navy's airsickness rehabilitation program.
Psychologists in the Psychiatry Department are responsible for conducting the
biofeedback training. The program is divided into ten one-hour sessions conducted twice
daily for five days. Initially, the airsick-prone student becomes acquainted with
biofeedback theory and its relevance in the treatment of airsickness. Additionally, advice
is given to avoid particular foods, including milk, chocolate, MSG and alcohol. The
airsick-prone student is then instructed to schedule a vigorous one-hour physical workout
daily. Desensitization therapy will immediately follow at the conclusion of biofeedback
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training. Desensitization has proven to be a valid clinical tool in treatment of airsickness
(Banks et al., 1992).
The SPAD rotational-chair desensitization process consists of using progressive
increases of severity in cross-coupled stimulation under a self-paced schedule. The
airsick-prone student is seated on a rotating chair and secured in place by a qualified
technician. The individual is then rotated while conducting a series of head tilts,
changing head position every ten seconds. Each student is scheduled a one-hour session
in the morning and a one-hour session in the afternoon separated by a three-hour break.
The rate and direction of spin is alternated for each session, and the airsick-prone student
is encouraged to build up tolerance at each speed level to form progressive increases to
his or her degree of tolerance. Initial speed of rotation is set at four rpm and increased or
decreased in two-rpm increments. Sessions are aborted if the student becomes nauseated,
vomits or is otherwise incapacitated. An individual is considered proficient and returned
to flight status upon attainment of a spin rate of 20 rpm for 40 minutes without any
difficulties or problems. The average time amongst SPAD participants to obtain
proficiency is 45 to 60 days. (NOMI, 1997)
It is known the SPAD program can help student aviators adapt to symptoms of
motion sickness, such as nausea. In addition, students participating in the SPAD program
may also feel symptoms that are not often recognized as motion sickness, including




It is common knowledge that motion can cause drowsiness (e.g. rocking a baby to
sleep), but it was not until 1976 at NAMRL, NAS Pensacola, that Graybiel and Knepton
explicitly identified the "Sopite Syndrome" as a "sometimes sole manifestation of motion
sickness" (Graybiel & Knepton, 1976). As stated earlier, typical characteristics or
symptoms of the syndrome in addition to drowsiness are chronic fatigue, yawning, the
disinclination to perform work, either physical or mental, and the lack of desire to
participate in group activities (Graybiel & Knepton, 1976). This evidence had been
gathered in large part from thorough and methodical observations in connections with
experiments conducted in slow rotation rooms at NAMRL. Additionally, the scientists
noticed different forms or types of related symptoms such as irritability, daydreaming,
difficulty in concentrating, sleep interruptions, lack of interest or concern, increased
laziness, and frequent napping (Lawson & Mead, 1997).
One of the significant symptoms in the diagnostic criteria of motion sickness is
drowsiness. In addition to drowsiness, other cardinal symptoms are vomiting, nausea,
change in skin color, cold sweating, and increased salvation (Miller & Graybiel, 1974;
Graybiel, Wood, Miller, & Cramer, 1968). These results indicate that the diagnostic
symptoms of a specific case of Sopite Syndrome are distinctive and separate from that of
motion sickness except for the common trait of drowsiness.
Generally, the symptoms characteristic of Sopite Syndrome are blended together
with different symptoms but under two circumstances the Sopite Syndrome constitutes
the main or sole process open to view and readily perceived in respect to motion sickness
(Graybiel & Knepton, 1976). One such circumstance is identified as the point at which
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the magnitude of the eliciting stimuli is at or approaching an individual's susceptibility;
at this point the syndrome is evoked in the presence or absence of other motion sickness
symptoms (Lawson & Mead, 1997). Therefore, Sopite Syndrome can be present in the
absence of more apparent symptoms of motion sickness such as nausea and vomiting
(Graybiel et al., 1968; Miller & Graybiel, 1974). The second circumstance takes place
during the course of prolonged exposure in a motion environment and at some point the
individual adapts to the environment resulting in the sudden or gradual disappearance of
motion sickness symptoms, except for reactions characteristic of Sopite Syndrome
(Lawson & Mead, 1997). Therefore, Lawson and Mead (1997) explain that Sopite
Syndrome characteristics can last long after nausea and vomiting have subsided and can
be debilitating to some individuals.
The above was noticed in 1965, when four aviators were exposed to a rotating
environment for a period of twelve days (Graybiel et al., 1965). Lawson and Mead
(1997) state the candidates chosen were two Navy and two Marine Corps officers who
had completed the acrobatic stage of flight training. Each was highly motivated and
instructed in the importance of the experiment on the space effort. Additional selection
factors consisted of good general fitness and mental discipline and a history of less than
average susceptibility to motion sickness. However, even after adapting to nauseating
rstimuli each of the four showed signs of Sopite Syndrome including an episode in which
one Marine Corps officer fell asleep on watch (Graybiel et al., 1965). Therefore, besides
the difference in symptoms, Sopite Syndrome appears to occur at different periods in
time in respect to the development and persistence of motion sickness (Lawson & Mead,
1997).
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Graybiel and Kneapton discovered the fact that the time course of Sopite
Syndrome differs somewhat from that of the general symptomology of motion sickness.
Therefore, instances of Sopite Syndrome symptoms can occur either before or after the
disappearance of typical symptoms of motion sickness. This apparent difference in the
time course of symptoms provides further evidence that the existence of Sopite Syndrome
is a separate distinct identity to that defined by the cardinal symptoms of motion sickness.
Regular motion sickness usually consists of nausea, vomiting, cold sweating,
increased salvation, flushing/warmth, pallor, headache, and dizziness. During a
participant's SPAD session such effects will usually arise while conducting head
movements and then start to subside promptly upon completion of a SPAD session. In
addition to the symptoms identified above, participants frequently report drowsiness.
Researchers credit these feelings of drowsiness in some degree as part of Sopite
Syndrome (Graybiel & Knepton, 1976).
Lawson and Mead (1997) state that the most prominent symptom of Sopite
Syndrome is uncharacteristic episodes of drowsiness, in particular when the unusual
motion has just ceased. These episodes include drowsiness at unusual times; more
frequent episodes of drowsiness than usual; drowsiness at the normal time(s), but
stronger than usual; frequent yawning; having to fight to keep from falling asleep;
lethargy; stupor; inattentiveness or loss of ability to concentrate; daydreaming; needing to
take a nap (if that is not normal for an individual); and going to bed earlier (or waking up
later) than normal (Clark, 1996).
In addition to drowsiness, certain mood changes might take place with the Sopite
Syndrome. Comprising these mood changes are disinclination to work; desire to be left
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alone (not wanting to participate in group activities); complaining; emotional depression;
apathy; lethargy; melancholy; and irritability (Lawson & Mead, 1997). These mood
changes may occur to a participant during a SPAD session. However, such shifts in
mood are thought to be more frequent and noticeable some time subsequently following a
SPAD session (Clark, 1996).
It is clear from the evidence presented that Sopite Syndrome is actually capable of
developing into a significant source of danger. Unfortunately, in the past twenty years,
Sopite Syndrome has rarely received formal recognition (Mead & Lawson, 1997).
Therefore, the potential impact of Sopite Syndrome in the fields of transportation,
specifically civilian and military aviation, is not generally recognized. Lawson and Mead
(1997) explain that the key components of drowsiness and mood shifts can pose a high
threat to individuals who perform in such activities and others who depend on them.
These factors may have profound implications on military crew coordination and could
threaten mission objectives.
F. SURVEY METHODOLOGY
In the past few decades, surveys have been used extensively in resolving a
particular person's past experiences to motion sickness (Kennedy, 1975; Lentz & Collins,
1977; Strongin & Charlton, 1991; Golding, Phil, & Strott, 1995). The fundamental
components in the majority of the studies are extremely similar. An inquiry into each
participant's frequency and level of severity with respect to motion sickness and its
cardinal symptoms is quite prevalent. Furthermore, the various modes of transportation
that elicit motion sickness are commonly queried. Such data is then analyzed to provide
a taxonomy as to the participant's susceptibility.
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A primary advantage in conducting a survey is that the researchers can sample
motion sickness experience over a wide range of provoking conditions without having to
expose participants to actual stimuli (Reason & Brand, 1975). Fowler (1993) discusses
various considerations in choosing a method of data collection. Group- administered
surveys are commonly used in motion sickness studies because they are quick to
administer and score, and overall participants do not have difficulty recalling motion
sickness experiences. Furthermore, participants do not resist from partaking in such
studies since motion sickness is not a potentially sensitive subject such as, for example,
alcohol use and family planning techniques. Above all, Reason and Brand (1975) state
that the reliability and validity of motion sickness surveys have been established in many
studies.
Motion sickness surveys do have drawbacks in their means of assessment.
Participants may not always answer questions correctly for fear of being rejected or to
avoid adverse treatment. Applicants for flight training meet this profile. However,
Reason and Brand (1975) comment that student aviators are more liable to tell the truth
when participating in a motion sickness survey than experienced aviators. A significant
problem with surveys is that they are unable to measure an individual's motion sickness
with a fine degree of accuracy. Reason and Brand (1975) indicate a potential for error is
that an individual's susceptibility score (based on how often episodes occurred in the
past) is inclined to reflect the individual's travel experience as well as susceptibility. For
example, an individual who travels frequently and on various modes of transportation is
likely to report a higher incidence of motion sickness than an individual who hardly
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travels at all with few means of transportation. Survey design or appropriate weighting
of scores can overcome such errors.
G. SUMMARY
Although little information existed in literature review to specifically address the
research questions, a simple diagnostic criterion to determine selection of SPAD
participants into Sopite and Non-Sopite group membership was developed. The primary
symptoms used to develop the diagnostic criterion originated from the slow- rotation
room studies conducted at NAMRL in Pensacola, FL. These symptoms include, but are
not limited to: drowsiness, chronic fatigue, yawning, the disinclination to perform work,
and the lack of desire to participate in group activities (Graybiel & Knepton, 1976).
Studies further indicated that the diagnostic symptoms of Sopite Syndrome are
distinctive and separate from that of motion sickness (Miller & Graybiel, 1974).
Additionally, Sopite Syndrome appears to occur at different periods in time when
compared to the development and persistence of motion sickness (Lawson & Mead,
1997). These findings provided the perception necessary to address the questions
concerning descriptive statistics and correlations between scales. Recent studies have
been devoted to the etiology of Sopite Syndrome to further refine the symptomology and
identification process (NAMRL, 1996). Therefore, the current research being conducted
by NAMRL has special significance for military aviation.
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III. DATA AND METHODOLOGY
A. DATA COLLECTION
1. Subjects
The study consisted of 60 Naval aviators who participated in the SPAD program
within the last six years. The average age was 28.3 years (standard deviation = 2.6
years), ranging from 23-34 years. All subjects were asked to participate anonymously in
the study regarding their SPAD experience. The participants had previously been
referred to the SPAD program for motion sickness treatment.
2. Instrument
The SPAD survey consisted of seven individual scales, each focusing on a distinct
element: Background and Habits, Sleep, Motion Sickness during SPAD Training, Mood,
Drowsiness during SPAD Training, Fatigue, and Motion Experience. The scales are
defined as follows:
(1) The Background and Habits scale requested information on whether the
respondents were officially returned to flight status after SPAD training and their current
duty assignments. This scale also requested the respondents to compare their normal
consumption of alcohol, nicotine, caffeine, and prescription or non-prescription drugs
during SPAD training to their usual or customary amounts.
(2) The Sleep scale requested that the respondents note which statements
regarding sleep were true, both during SPAD (at their most challenging SPAD day) and
in general (everyday life outside the SPAD experience).
(3) The Motion Sickness during SPAD Training scale consisted of two parts. For
the first, the respondents were asked to estimate the amount of motion sickness
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experienced during SPAD and the amount experienced during a typical day in "normal"
life. These experiences were rated on a visual analog scale ranging from zero (none) to
100 (extreme). The second part was a motion sickness symptom checklist to be
completed for the time during SPAD and in general. The severity of the symptoms were
evaluated by the respondents on a 4-point rating scale: none = 0, minimal = 1, minor = 2,
and major = 3.
(4) The Mood scale consisted of a list of words describing feelings or moods.
For each word the respondents were requested to rate their typical feelings both during
SPAD training and in general. These responses were evaluated utilizing a 4-point rating
scale: "vv" = definitely feel, "v" = feel slightly, "?" = cannot decide, and "no" =
definitely do not feel.
(5) The Drowsiness during SPAD Training scale consisted of two parts. For the
first, the respondents were asked to estimate the amount of sleepiness and lowered
arousal levels typically experienced during SPAD and the amount typically experienced
during everyday life. These experiences were rated on a visual analog scale ranging from
zero (none) to 100 (extreme). The second part was a sleepiness rating for which the
respondent was requested to rate their typical level of alertness during SPAD and in
general. The responses were evaluated on a 1 to 7 sleepiness scale (1 = feeling active and
vital, alert, wide awake; 2 = functioning at high level, but not at peak, able to concentrate;
3 = relaxed, awake, not at full alertness, responsive; 4 = a little foggy, not at peak, let
down; 5 = fogginess, beginning to lose interest in remaining awake, slowed down; 6 =
sleepiness, prefer to be lying down, fighting sleep, woozy; and 7 = almost in reverie,
sleep onset soon, lost struggle to remain awake).
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(6) The Fatigue scale requested that the respondents note which statements
regarding fatigue were true, for their experiences both during SPAD and in general.
(7) The Motion Experience scale consisted of a list of various motions; the
respondent was requested to estimate the number of times they had experienced each of
them since the age of twelve. The number of experiences were broken down into 4
frequency categories: 1 to 10; 10 to 20; 20 to 30; and greater than 30. The respondent
was also requested to describe how often they vomited, felt nausea, or felt drowsy during
or after each motion. These frequencies were measured in five categories: "never" = less
than 5% of the time; "rarely" = 5% to 34% of the time; "seldom" = 35% to 64% of the
time; "frequently" = 65% to 95% of the time; and "always" = greater than 95% of the
time.
3. Procedure
In order to eliminate any effect of order of presentation, the seven scales for each
of the surveys were placed together at random. This was accomplished by generating
random numbers to represent each of the respective parts, and from these numbers the
individual surveys had the scales permutated. Each survey was assigned a subject
number to allow for confidentiality. The surveys were mailed in October 1996 to 136
Naval aviators who had participated in the SPAD program within the last six years. Each
survey package contained a self-addressed, stamped envelope and a set of instruction. Of





The SPAD survey responses were entered into an Excel spreadsheet. The code
used to enter the data was specific to each type of scale. A Quality Assurance process to
ensure accurate data entry was conducted with a three- percent error. The code for each
scale was as follows:
(1) Background and Habits scale responses were recorded in the following
manner: either a 1 or was recorded corresponding to male or female. For the question
regarding the participant's return to flight status, either a 1 or was recorded for a
response of "Yes" or "No" respectively. With regard to the usual amount of alcohol
consumed in a typical week during SPAD training, a 1 was recorded for a response of
less than 1 drink/week, a 2 for 1 to 3 drinks, a 3 for 4 to 7 drinks, a 4 for 8 to 12 drinks,
and a 5 for greater than or equal to 13 drinks. The question regarding nicotine usage in a
typical day during SPAD training was recorded as follows: a 1 was recorded for a
response of less than 1 dose/day, a 2 for 1 to 10 doses, a 3 for 1 1 to 20 doses, a 4 for 21 to
30 doses, and a 5 for greater than or equal to 30 doses. For caffeine usage during a
typical day during SPAD training a 1 was recorded for a response of less than 1 serving
per day, a 2 for 1 to 2 servings, a 3 for 3 to 4 servings, a 4 for 5 to 6 servings, and a 5 for
greater than or equal to 7 servings. The responses provided regarding any prescription or
non-prescription drug usage were recorded as provided. For each of the above questions,
when asked to compare the responses with their usual or customary amounts, the
corresponding values of 1, 2, 3, 4, or 5 were recorded for each response provided.
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(2) Sleep scale responses were recorded as follows: for each statement both
during SPAD and in general, either a 1 or was recorded corresponding to each response
of "Yes" or "No" respectively.
(3) Motion Sickness during SPAD training scale responses were marked, and a
ruler was utilized to record the corresponding value from the visual analog scale (0 - 100
mm). For the second part, the corresponding value of 0, 1, 2, or 3 was recorded.
(4) Mood scale responses for each of the words were recorded as either a 1, 2, 3,
or 4, which correspond to "vv", "v", "?", and "no" respectively (see A.2.4).
(5) Drowsiness during SPAD training scale responses were marked; a ruler was
utilized to record the corresponding value from the visual analog scale (0 - 100 mm).
For the second part, the corresponding value of 1 to 7 was recorded.
(6) Fatigue scale responses were recorded as follows: for each statement both
during SPAD and in general, either a 1 or was recorded corresponding to each response
of "Yes" or "No" respectively.
(7) Motion Experience scale responses were recorded as follows: the number of
experiences were recorded as a 1, 2, 3, 4, or 5 corresponding to "none," 1-10, 10-20, 20-
30, and greater than 30. The frequency of vomit, nausea, and drowsiness were recorded
as either a 1, 2, 3, 4, or 5 corresponding to a response of either "never," "rarely,"
"seldom," "frequently," or "always" respectively.
2. Statistical Analysis
The study of the existence of Sopite Syndrome starts with exploratory analysis of
the survey scales and the relationships that may exist between the respective scales. The
exploratory analysis is performed through the use of descriptive statistics, which describe
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the data in terms of measures of central tendencies and dispersions. The measures for
central tendencies utilized are the mean, for the added values and/or numerical data, and
the mode, for the ordinal data. The measures of dispersion or spread utilized are the
standard deviation and the inter-quartile range (IQR). Graphical presentations of the
distribution of the paired differences between the two conditions, "During SPAD" and
"In General," for each scale are also provided through the use of histograms.
The Wilcoxon Signed-Rank Test is conducted to test whether the two conditions
listed above are different. This non-parametric test is performed for each of the survey
scales separately, allowing for comparison between the two conditions. The Spearman
rank correlation, or Spearman's rho, is utilized to describe the relationship between any
two of the respective scales. A test statistic associated with this non-parametric statistic
is performed for each possible combination of scales.
Permutation tests are utilized to help substantiate group compositions into
Sopite/Non-Sopite candidates. The Fisher test is conducted to test whether a relationship
exists between Sopite/Non-Sopite classification and flight status. The Mann-Whitney
test is conducted to test whether the two groups, Sopite and Non-Sopite, come from the
same distribution. This non-parametric test is performed for each survey scale separately,




This section provides the detailed descriptive statistics for the Sleep, Motion
Sickness during SPAD Training, Mood, Drowsiness during SPAD Training, and Fatigue
scales. These statistics are utilized to determine the central tendencies and dispersion of
the responses provided for each of the respective scales. Since these scales pertain to
behavioral data, all of the comparisons are made using the paired differences between the
two conditions, "During SPAD" and "In General." Further we utilize the Wilcoxon
Signed-Rank Test applied to the paired differences. This is a two-sided test. Hence, the
null hypothesis (H ) to-be tested was defined as follows: no difference exists between the
"During SPAD" and "In General" responses.
1. Sleep Scale
The sleep scale responses for each statement were recorded for both "During
SPAD" and "In General." From this data, the total number of affirmative responses in
each of the categories was tabulated for each respondent. These totals were utilized to
calculate the paired differences between the total number of affirmative responses
provided both "During SPAD" and "In General" for each of the respondents. The mean,
standard deviation, and the first and third quartiles for these paired differences are
summarized in Table 4. 1 . Note that there were more sleep disturbances reported "During
SPAD" than "In General." The actual number of respondents who report an increase in
sleep disturbances during SPAD training was 32 out of 60 (53%). Using an alpha level











During SPAD 6.45 4.55 3 9
In General 5.35 4.44 2 8
Difference 1.10 3.73 -1 3
Table 4.1 Sleep Scale Responses.
The IQR is the distance between the first and third quartile and, by spanning the
middle 50% of the data, it measures the spread or width of the distribution of data. As
depicted in Table 4.1, the first quartile for the paired difference scores is Ql = -1 and the
third quartile for the paired difference scores is Q3 = 3, thus the IQR = 4. To help
illustrate the distribution of the change in scores between the "During SPAD" and "In
General" conditions for each respondent, a histogram is provided in Figure 4.1.
Figure 4. 1 Histogram of Sleep Scale Paired Difference Scores.
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2. Motion Sickness during SPAD Training Scale
The first part of the motion sickness scale consisted of a visual analog scale in
which the respondents estimated the amount of motion sickness experienced "During
SPAD" and the amount experienced "In General." From these two responses, the
differences in the amount of motion sickness experienced by each of the respondents
were calculated. These paired differences were then used to compute the mean, standard
deviation, and the first and third quartiles. The results are summarized in Table 4.2.
Note that the mean response for the amount of motion sickness experienced "During
SPAD" was much greater than that of "In General." The actual number of respondents
who reported an increase in the severity of motion sickness experienced during SPAD
training was 59 out of 60 (98%). With an alpha level of 0.05, the increase in severity of
motion sickness experienced was statistically significant (Z = 6.68, p = 0.00). The
changes in the motion sickness scores between the two conditions, as reported by each of
the respondents, are illustrated in Figure 4.2. Note that the inter-quartile range (IQR =










During SPAD 78.59 20.47 71.50 95.00
In General 10.08 15.93 1.00 13.50
Difference 67.02 24.49 54.75 80.50
Table 4.2 Motion Sickness Scale Responses.
The second portion of the motion sickness scale consisted of a list of motion
sickness symptoms in which the respondents rated the severity of the symptoms
experienced both "During SPAD" and "In General." From these values the differences in
severity experienced by each respondent both "During SPAD" and "In General" were
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calculated. These paired differences were used to compute the mode responses and the
number of subjects reporting an increase in severity for each of the symptoms. These
values are summarized in Table 4.3. Note that the mode responses were greater during
SPAD training for all of the symptoms except "retching or vomiting." Additionally, all
the increases in symptom severity between the two conditions were statistically



















Change in Motion Sickness Scores
















Nausea 3 97% 9.60 0.00
Salivation 2 93% 9.23 0.00
Cold Sweating 3 88% 8.73 0.00
Pallor 2 88% 8.56 0.00
Drowsiness 3 87% 7.43 0.00
Headache 3 87% 7.54 0.00
Flushing/
Warmth
2 83% 8.13 0.00
Dizziness 3 87% 8.09 0.00
Stomach
Awareness




Table 4.3 Motion Sickness Symptom Responses.
3. Mood Scale
The mood scale requested the respondents to rate their feelings toward 49
different moods both "During SPAD" and "In General." After a literature review, the
author selected 16 of the 49 moods that appeared to be symptomatic of Sopite Syndrome.
This reduction in moods was verified utilizing the empirical cumulative distribution
function (cdf) technique. Through this technique, the cdf s were calculated for all of the
49 moods and then the respective values were examined to see which moods had the
largest increase in their cdf s to the right of zero. This corresponded to the greatest
increase between "During SPAD" and "In General." Some examples of the empirical cdf
values are displayed in Table 4.4.
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Moods -3 -2 -1 1 2 3
Active 0.00 0.00 0.00 0.22 0.35 0.65 1.00
Tired 0.00 0.00 0.03 0.25 0.43 0.67 1.00
Calm 0.00 0.027 0.07 0.53 0.77 0.93 1.00
Placid 0.03 0.08 0.23 0.65 0.80 0.95 1.00
Table 4.4 Empirical Cumulative Distribution Functions for Selected Moods.
As depicted in Table 4.4, the moods "active" and "tired" only have 22% and 25%
of the cumulative distribution accounted for to the left of and including zero, which
indicates that the majority of the paired difference scores have positive increases. In
contrast, the moods "calm" and "placid" have 53% and 65% of the cumulative
distribution already accounted for to the left of and including zero, which indicates that a
majority of the paired difference scores possess decreasing severity or no change at all.
The resulting moods with the largest increases in their cdf s to the right of zero
corresponded to the same 16 moods chosen by the author after the literature review.
These 16 moods and their corresponding mode responses are presented in Table 4.5.
Note that some of the moods had increases in responses, whereas others had decreases.
This was due to the design of the rating scale. The rating scale did not take into account
that some moods such as "sleepy," "grouchy," and "tired" are measured in the reverse
order of such moods as "peppy," "energetic," and "lively." The moods that are measured
in reverse order (a decrease vice increase in severity) are annotated with an asterisk in
Table 4.5. Once the 16 moods were selected, the total change across all moods between
the two conditions was calculated for each of the respondents. These cumulative paired
differences for each respondent were then used to compute the mean, standard deviation,
and first and third quartiles. The resulting mean was 22.63, the standard deviation was
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12.06, and the first and third quartiles were 14 and 34 respectively. The distribution of
the changes in the mood scores between the two conditions, as reported by each of the
respondents, is shown in Figure 4.3. This figure also displays the spread of the








Peppy 4 2 73% (*)
Sleepy 1 4 73%
Grouchy 2 4 48%
Energetic 4 2 77% (*)
Tired 1 4 75%
Vigorous 4 2 85% (*)
Drowsy 1 4 80%
Lively 4 2 83% (*)
Wide-awake 4 1 73% (*)
Full-of-pep 4 2 78% (*)
Quiet 1 2 52%
Concentrating 4 2 58% (*)
Sluggish 1 4 82%
Wakeful 4 2 65% (*)
Active 4 1 78% (*)
Tense 2 4 45%
Table 4.5 Mood Scale Responses.
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Figure 4.3 Histogram of Mood Scale Paired Difference Scores.
4. Drowsiness during SPAD Training Scale
The first portion of the drowsiness scale consisted of a visual analog scale in
which the respondents were requested to estimate their sleepiness both "During SPAD"
and "In General." These responses were utilized to calculate the paired differences in
sleepiness scores reported by each of the respondents during the two conditions. These
values were then utilized to compute the mean, standard deviation, and the first and third
quartiles of the responses. The results are summarized in Table 4.6. Note that the mean
response for the amount of sleepiness experienced "During SPAD" was much greater
than that of "In General." The actual number of respondents who reported an increase in
the amount of sleepiness experienced during SPAD training was 52 out of 60 (87%).
With an alpha level of 0.05, the increase in sleepiness was statistically significant
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(Z = 6.26, p = 0.00). The changes in sleepiness scores between the two conditions, as
reported by each of the respondents, and the spread of the distribution represented by the










During SPAD 66.10 26.65 53.50 84.00
In General 22.35 19.74 6.00 31.00
Difference 42.65 31.65 24.75 69.25
Table 4.6 Drowsiness during SPAD Training Scale Responses.
Figure 4.4 Histogram of Drowsiness Scale Paired Difference Scores.
The second portion of the drowsiness scale consisted of two rating scales in which
the respondents rated their levels of alertness for both conditions, "During SPAD" and
"In General." These respective values were utilized to calculate the paired differences in
alertness between the two conditions for each of the respondents. The mode responses
for "During SPAD" and "In General" are depicted in Table 4.7. Note that the mode
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response for "During SPAD" was greater than the mode response for "In General." The
actual number of respondents who reported a decrease in alertness during SPAD training
was 54 out of 60 (90%). With an alpha level of 0.05, the increase in sleepiness rating
was statistically significantly (Z = 6.69, p = 0.00). The changes in scores between the two
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Figure 4.5. Histogram of Sleepiness Rating Scale Paired Difference Scores.
5. Fatigue Scale
The fatigue scale responses for each statement were recorded for both "During
SPAD" and "In General." The number of affirmative responses in each category was
then tabulated for each respondent. These totals were utilized to calculate the paired
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differences between the total number of responses provided both "During SPAD" and "In
General." The mean, standard deviation, and the first and third quartiles for these paired
differences are summarized in Table 4.8. Note that there were more fatigue disturbances
reported "During SPAD" than "In General." The actual number of respondents who
reported an increase in fatigue disturbances during SPAD training was 42 out of 60
(70%). With an alpha level of 0.05, the increase in fatigue disturbances was statistically
significant (Z = 5.67, p = 0.00). The changes in fatigue scores between the two
conditions, as reported by each of the respondents, and the spread of the distribution










During SPAD 2.70 2.04 1 4
In General 0.53 1.19 1
Difference 2.17 2.28 4
Table 4.8 Fatigue Scale Responses.
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Figure 4.6 Histogram of Fatigue Scale Paired Difference Scores.
B. CORRELATIONS BETWEEN SCALES
The Spearman's rho was utilized to test whether a relationship between each of
the scales existed. The values for the Spearman's rho can range in value from +1 to -1,
with the positive and negative one being interpreted as a perfect correlation. According
to Fink (1995), a conservative rule of thumb for correlation values is as follows: a value
from to ±0.25 indicates that there is little to no relationship, a value from ±0.26 to
±0.50 indicates a fair degree of relationship, and a value from ±0.51 to ±0.75 indicates a
moderate to good relationship. The author goes on to explain that for some social science
disciplines, a correlation of ±0.26 to ±0.50 is considered quite high. The resulting values
for each of the possible combinations of scales are summarized in Table 4. 10. Testing
was performed with an alpha level of 0.05. Because 15 individual tests were conducted,
one for each combination of scales, the significance level was reduced to 0.003 (0.05/15).
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With an alpha level of 0.003, no combination with motion sickness was statistically
significant under the null hypothesis that the correlation between each respective pair of
scales is zero. As shown in Table 4.9, for those combinations that were statistically
significant, the Spearman's rho values ranged from 0.36 to 0.64, which indicates a high
correlation for this social science discipline.
Correlation Spearman's rho p-value
Drowsiness/Sleepiness Rating 0.61 0.00
Drowsiness/Fatigue 0.47 0.00
Drowsiness/Sleep 0.47 0.00
Drowsiness/Motion Sickness 0.26 0.05
Drowsiness/Mood 0.51 0.00
Sleepiness Rating/Fatigue 0.51 0.00
Sleepiness Rating/Sleep 0.54 0.00
Sleepiness Rating/Motion Sickness 0.18 0.17
Sleepiness Rating/Mood 0.49 0.00
Fatigue/Sleep 0.64 0.00
Fatigue/Motion Sickness 0.25 0.06
Fatigue/Mood 0.54 0.00
Sleep/Motion Sickness 0.32 0.01
Sleep/Mood 0.55 0.00
Motion Sickness/Mood 0.36 0.01
Table 4.9 Measure of Relationships between Scales.
C. GROUP COMPOSITION
The method utilized to break the subjects into respective groups based upon the
literature was as follows: everyone who had positive increases in sleep, fatigue,
drowsiness, and sleepiness rating scales were classified as exhibiting symptoms of Sopite
Syndrome. Those who did not have positive increase in all of the respective categories
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were classified as not exhibiting symptoms of Sopite Syndrome. The results of the





Sopite Candidates 27 45%
Non-Sopite Candidates 33 55%
Table 4.10 Sopite/Non-Sopite Classification Groups.
The Sopite and Non-Sopite classification groups were then further subdivided into
those candidates who were successfully returned to flight status and those who were not.
These new classifications are displayed in Table 4. 1 1 . To help illustrate the group
compositions, a bar chart is provided in Figure 4.7. The two-sided Fisher test was
utilized to test whether a relationship exists between Sopite/Non-Sopite classification and
flight status. Hence, the null hypothesis (H ) to be tested was defined as follows:
Sopite/Non-Sopite classification and flight status are statistically independent. The
Fisher test yielded a p-value = 0.22, thus with an alpha value of 0.05, the null hypothesis
can not be rejected. Thus, there is not enough evidence to indicate a relationship exists






Sopite Candidates 19 8 27
Non-Sopite Candidates 28 5 33
Total 47 13 60





















Figure 4.7 Bar Chart of Classification Groups.
Further evidence to substantiate the methodology for the classification of those
respondents exhibiting characteristics of Sopite Syndrome was obtained through a
permutation test. The permutation test utilized data from the mood scale. The rationale
for this choice was two-fold: 1) mood changes are defined in the literature as being
characteristic of Sopite Syndrome and 2) this specific data was not utilized in the
selection of the Sopite Syndrome candidates. Hence, the null hypothesis (H ) was
defined as follows: the Sopite candidates' level of mood changes is the same as that of
the rest of the sample population. If the null hypothesis is true, the sum of the 27 scores
for the Sopite candidates should be comparable to the sum of any other random set of 27
scores from the sample population in the size of mood changes experienced. In order to
test the null hypothesis a function was written in S-PLUS to generate the sum of 27
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numbers chosen randomly from the original 60 mood difference scores (a copy of the S-
PLUS code is included in Appendix A).
Twenty-seven values were utilized to correspond to the number of Sopite
candidates identified. The sums that were generated were compared to the sum of the
mood difference scores of those respondents identified as exhibiting symptoms of Sopite
Syndrome. A running tally was kept as to the number of times that the generated sum
exceeded the sum of the Sopite candidates' scores. The results of the permutation test
showed there was a statistically significant (p < 0.05) difference between the average size
of mood changes experienced by the Sopite Syndrome candidates from that of the rest of
the population. Thus, the null hypothesis that there is no difference in mood changes
between those respondents exhibiting symptoms of Sopite Syndrome and the sample
population is rejected. This test therefore supports the methodology used in the selection
of Sopite Syndrome candidates.
D. DESCRIPTIVE STATISTICS FOR GROUP CLASSIFICATIONS
From the original group of 60 former SPAD participants, 27 of them were
classified as exhibiting symptoms characteristic of Sopite Syndrome while the remaining
33 of them were classified as not exhibiting symptoms characteristic of Sopite Syndrome.
The paired difference scores between "During SPAD" and "In General" for both of the
respective groups were utilized to compute the mean, standard deviation, and the first and
third quartiles. Table 4.12 summarizes the values for Sopite/Non-Sopite groups. The
degree in which the Sopite group exhibited increased levels of severity in each of the
scales was much greater than that experienced by the Non-Sopite group. This
observation helps to support the idea that differences between the two groups with
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respect to the different scales do exist. To help illustrate the differences between the two
groups, a box plot for each of the scales is provided in Figure 4.8.









































































































































Figure 4.8 Box Plots of Sopite/Non-Sopite Groups.
42
The paired differences between "During SPAD" and "In General" for the four
categories (Sopite candidate and returned to flight status; Sopite candidate and not
returned to flight status; Non-Sopite candidate and returned to flight status; and Non-
Sopite candidate and not returned to flight status) were utilized to compute the mean
values. These values are displayed in Table 4.13. The degree of severity between those
participants who were not returned to flight status and those who were returned to flight
status for both the Sopite and Non-Sopite groups was larger in each of the respective
cases. This illustrates that those student aviators not returned to flight status experienced
more severe symptoms.
Survey Scale S/RTN S/NRTN NS/RTN NS/NRTN
Sleep 3.53 5.38 -1.36 -1.20
Motion Sickness 75.32 74.63 59.46 67.80
Mood 29.00 31.88 15.54 23.40
Drowsiness 57.84 62.88 27.82 35.60
Sleepiness Rating 3.58 4.00 2.07 3.00
Fatigue 3.05 4.88 0.61 3.20
Table 4. 1 3 Mean Values for Classification Groups.
E. STATISTICAL INFERENCE BETWEEN GROUPS
The Mann-Whitney test was utilized to perform simultaneous tests for whether
the differences between the two groups, Sopite and Non-Sopite, with respect to the
various scales (six in all) are statistically significant. This nonparametric test is a
procedure to test whether the two groups came from the same distribution. Hence, the
null hypothesis (H ) was defined as follows: the two groups are from the same
distribution. If the null hypothesis is true, the p-value for the respective scales should be
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greater than an alpha level of 0.008 (0.05/6). The resulting Z and p-values from the
Mann-Whitney test are summarized in Table 4.14.
Survey Scales Z value Mann-Whitney Test
p-value
Sleep 6.41 0.00
Motion Sickness 1.96 0.05
Mood 4.10 0.00
Drowsiness 3.60 0.00
Sleepiness Rating 3.71 0.00
Fatigue 4.67 0.00
Table 4. 14 Significance Values for Independent Two-Sample Case.
As indicated by the values displayed in Table 4.14, the difference between the
groups was statistically significant for each of the scales, excluding motion sickness.
Therefore, the null hypothesis was rejected for each of the scales, excluding motion
sickness. From this we may conclude that the two groups were not drawn from the same
distribution.
F. SLEEP/FATIGUE QUESTIONS
The sleep scale consisted of a series of 38 questions pertaining to various sleep
disturbances (these questions are included in Appendix B). Of these 38 questions, 15
were discarded because less than 5% of the sample population provided an affirmative
response to these questions. The discarded questions therefore did not allow for any
differentiation between groups. The summary of the response percentages for the
remaining questions is provided in Table 4. 15. Among respondents that were returned to
flight status, there were nine specific questions (numbers 1, 5, 6, 9, 15, 19, 22, 26, and
38) that had larger response percentages (at least 15% larger) for Sopite candidates than
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those of Non-Sopite candidates. Among respondents that were not returned to flight
status, there were eight specific questions (numbers 1, 5, 6, 9, 15, 19, 22, and 38) that had
percentages larger in the same way. Each of these same eight questions appear in the
previous nine. This implies that these eight questions may be indicators for successfully
























1 42% 18% 38% 20%
4 26% 21% 38% 60%
5 84% 50% 100% 80%
6 26% 4% 63% 0%
9 84% 32% 88% 60%
10 11% 14% 13% 40%
11 5% 25% 0% 0%
12 16% 25% 13% 0%
15 47% 25% 38% 20%
16 16% 11% 0% 20%
17 26% 29% 13% 0%
19 53% 14% 63% 20%
22 42% 4% 63% 40%
23 21% 25% 13% 20%
24 5% 7% 13% 20%
25 26% 46% 25% 20%
26 21% 0% 38% 40%
28 11% 7% 13% 0%
33 32% 29% 63% 80%
34 26% 21% 38% 40%
36 5% 0% 13% 0%
37 0% 7% 25% 20%
38 79% 36% 63% 40%
Table 4. 15 Percentage of Respondents
Affirmative Responses
Within Each Group Who Reported
for the Sleep Scale.
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The fatigue scale consisted of ten questions (the questions are provided in
Appendix C). Of these ten questions, three were discarded because less than 2% of the
sample population provided an affirmative response to these questions. These discarded
questions therefore did not allow for any differentiation between groups. The summary


























1 84% 36% 100% 100%
2 42% 21% 63% 60%
3 84% 32% 88% 40%
6 5% 4% 38% 40%
8 47% 14% 75% 80%
9 42% 18% 63% 20%
10 16% 18% 75% 20%
Table 4.16 Percentage of Respondents Within Each Group Who Reported
Affirmative Responses for the Fatigue Scale.
Among those respondents who were returned to flight status, there were five
specific questions (numbers 1, 2, 3, 8, and 9) that had larger response percentages
(greater than 15%) for Sopite candidates than those of Non-Sopite candidates, while
among the other, three questions (numbers 3, 9, and 10) had response percentages larger
in this way. Note that questions three and nine appear for both groups. This implies that
these two questions may be indicators for successfully predicting Sopite candidates with
regard to fatigue disturbances.
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V. CONCLUSIONS AND RECOMMENDATIONS
A. CONCLUSIONS
The purpose of this study was to determine if personnel diagnosed with motion
sickness exhibited symptoms characteristic of Sopite Syndrome while participating in the
SPAD rehabilitation program. Exploratory data analysis and non-parametric techniques
were utilized in the research into symptoms consistent with Sopite Syndrome included.
Such procedures are frequently used by the behavioral scientist.
The thesis investigated and sought to answer six research questions. Specifically
addressed is the effect Sopite Syndrome may have on the successful completion of
treatment and ultimate return to flight status of a SPAD participant. The answers to the
six research questions are presented as follows:
1
.
Descriptive statistics were generated to illustrate the central tendencies and
dispersions for each survey scale. Individual scale results can be found in Chapter IV.
The Wilcoxon Signed-Rank Test was applied to each scale to determine whether the
paired differences between the conditions, "During SPAD" and "In General," were
statistically significant. Using an alpha level set at 0.05, the paired differences between
the two conditions were statistically significant for all scales. The actual percentages of
respondents who reported increases between the two conditions were 53% for the sleep
scale, 98% for the motion sickness scale, 45% to 85% for each of the 16 moods, 87% for
the drowsiness scale, 90% for the sleepiness rating scale, and 70% for the fatigue scale.
2. In analyzing the empirical cdf s, the original 49 moods were reduced to a total
of 16. The final 16 moods identified as those which are most prevalent in aviation
students who were referred to the SPAD rehabilitation program are as follows: peppy,
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sleepy, grouchy, energetic, tired, vigorous, drowsy, lively, wide-awake, full-of-pep, quiet,
concentrating, sluggish, wakeful, active, and tense.
3. The Spearman rho rank correlation statistic was used to measure the relations
between each possible combination of scales. The correlation values ranged from 0. 18 to
0.64 and are listed in Table 4.9. All combinations that did not include the motion
sickness scale were statistically significant. The fact that motion sickness was not
statistically significant was expected, since the sample population surveyed had been
previously diagnosed as susceptible to motion sickness. For those relationships that were
statistically significant, the correlation values ranged from 0.36 to 0.64, which indicates a
high correlation for behavioral data.
4. From the original sample population of 60 former SPAD participants, 27
(45%) of them exhibited symptoms characteristic of Sopite Syndrome. Of these 27
individuals, 19 (70%) of them were returned to flight status. Furthermore, of the 33
remaining SPAD participants not classified as exhibiting symptoms characteristic of
Sopite Syndrome, 28 (85%) were returned to flight status. The Fisher Exact Test was
applied to determine whether a relationship existed between Sopite/Non-Sopite
classification and flight status. Using an alpha level set at 0.05, there was not enough
evidence to indicate that a relationship existed. Thus, the apparent existence of Sopite
Syndrome does not alone affect the candidates' successful completion of treatment and
ultimate return to flight status.
5. Initial compositions of Sopite and Non-Sopite groups were determined through
literature with focus on primary symptom requirements and constraints. Selection criteria
were then validated using a permutation test with significant results (alpha = 0.05). The
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Mann-Whitney test was then utilized to determine the statistical significance between the
groups. With an alpha level set at 0.05, the differences between the two groups for each
of the respective survey scales were statistically significant. Such results enhance the
credibility of the claim that Sopite Syndrome exists.
6. With regards to the sleep scale, there were eight specific questions that may be
indicators for successfully predicting Sopite Syndrome candidates. These are questions
1, 5, 6, 9, 15, 19, 22, and 38, which are provided in Appendix B. With regards to the
fatigue scale, there were two specific questions that may be indicators for successfully
predicting Sopite candidates. These questions, numbers 3 and 9, are provided in
Appendix C. Such questions are highly correlated to the symptomology of Sopite
Syndrome as defined in the literature.
B. RECOMMENDATIONS
Since symptoms consistent with Sopite Syndrome were reported by 45% of the
SPAD participants, it is recommended that the SPAD survey be administered to other
aviation populations to assess its existence in the fleet. In the meantime, aviation
squadrons should be educated on the symptoms characteristic of Sopite Syndrome and
the potential dangers they may pose to aviators during flight. Due to the result that 19 out
of 27 (70%) of the former SPAD participants who exhibited symptoms characteristic of
"Sopite Syndrome successfully completed treatment and were returned to flight training, it
is recommended that a separate treatment program be developed for Sopite Syndrome.
Recently, the Navy has begun testing in the Human Disorientation Device (HDD)
at NAMRL to further investigate the existence of Sopite Syndrome. The research team is
currently gathering information on the physiological variables that may contribute to the
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apparent existence of Sopite Syndrome. It is recommended that the SPAD survey be
administered to the experiments' participants and then matched against the physiological
variables from the experiment. The data that is gathered from these experiments may be
used to determine the actual causes of Sopite Syndrome and to determine if there are any
methods by which the effects of Sopite Syndrome can be reduced or alleviated.
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APPENDIX A. S-PLUS CODE FOR PERMUTATION TEST
> boot
function (n, a, tot)
{
#
# Function name: boot
#
# This function will permutate 27 random numbers from the
# sample vector (a) provided. It will then compare the sum
# of these 27 numbers to the sum provided (tot) . The
# permutation will be performed n times and a tally of the
# number of sums generated that are larger than the sum
# provided will be taken.
#
#
# parameters: n = the number of iterations to perform
# a = the vector of scores to choose the 27
# random numbers from
# tot = the total value of the Sopite scores
# in the vector a
#
total <-
for(i in l:n) {
perm <- sample (a)
summ <- sum (perm [1 : 27]
)
if(summ > tot)





APPENDIX B. SLEEP SCALE QUESTIONS
1
.
I have been told that I snore.
2. I have been told that I hold my breath while I sleep.
3. I have high blood pressure.
4. My friends/family say I'm often grumpy and irritable.
5. I wish I had more energy.
6. I get morning headaches.
7. I often wake up grasping for breath.
8. I am overweight.
9. I often feel sleepy & struggle to remain alert during the day.
10. 1 frequently wake with a dry mouth.
1 1 . 1 have difficulty falling asleep.
12. Thoughts race through my mind & prevent me from getting to sleep.
13. 1 anticipate a problem with sleep several times a week.
14. 1 often wake up and have trouble going back to sleep.
15. 1 worry about things and have trouble relaxing.
16. 1 wake up earlier in the morning than I would like to.
17. 1 lie awake for half an hour or more before I fall asleep.
18. 1 often feel sad or depressed because I can't sleep.
19. 1 have trouble concentrating at work or school.
20. When I am angry or surprised, I feel like my muscles are going limp.
21.1 have fallen asleep while driving.
22. 1 often feel like I am in a daze.
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23. 1 have experienced vivid dreamlike scenes upon falling asleep or awakening.
24. 1 have fallen asleep in social settings such as movies or at a party.
25. 1 have vivid dreams soon after falling asleep or during naps.
26. 1 have "sleep attacks" during the day where I fall asleep no matter how hard I try to
stay awake.
27. 1 have episodes of feeling paralyzed during my sleep.
28. 1 wake up at night with an acid/sour taste in my mouth.
29. 1 wake up at night coughing or wheezing
30. 1 have frequent sore throats.
31.1 have heartburn at night.
32. During the night I suddenly wake up feeling like I am choking.
33. 1 have noticed (or others have commented) that parts of my body jerk during sleep.
34. 1 have been told that I kick and jerk during sleep.
35. When trying to go to sleep, I experience an aching or crawling sensation in my legs.
36. 1 have experienced leg pains and cramps at night.
37. Sometimes I can't keep my legs still at night, I just have to move them to feel
comfortable.
38. Even though I slept during the night, I feel sleepy during the day.
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APPENDIX C. FATIGUE SCALE QUESTIONS
1
.
I tend to feel persistent, unexplained or recurrent fatigue that does not seem to
depend upon my level of rest or exertion.
2. I tend to feel an impairment in my short term memory or concentration.
3. I tend to feel a reduction from my previous levels of occupational, educational, social
or personal activities.
4. I tend to get sore throats.
5. I tend to feel tender lymph nodes in my neck, armpits, or groin.
6. I tend to feel muscle pain.
7. I tend to feel multi-joint pain without joint swelling or redness.
8. I tend to feel headaches of a new type, pattern or severity.
9. I tend to have unrefreshing sleep.
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